2021 CLP - Crash & Burn: Cardiogenic Shock in 2021

Sarcoidosis

Psychosocial Evaluation for Advanced HF Therapies: Are we evaluating patients fairly?

FDA Special Session: Focus on HFSA Research Network

Digesting EMPEROR-Preserved: The Evolving Treatment of HFpEF and Use of SGLT2i

Referral for Advanced HF

Beyond PVR: Assessing and Managing the Dysfunctional Right Ventricle

Deep Learning for HF Medicine: A Practical Primer

JNC and Nursing New Investigator Award Announcements and Hyde Park

Recent Advances and Update on Myocarditis

Applying Genetics & Genomics in HF: Current Landscape & Future Directions

Substance use and Treatment in LVAD Candidate

Burned Out : Identifying and Managing Clinician Burnout and Mental Wellness

Late Breaking Clinical Trials I

Cardio-oncology

International Session: Universal Definition of HF (Joint Session ESC HFA / JHFS)

Optimizing LVAD Management

Failing Organs in Patients with Advanced HF, Will a Cardiac Fix the Rest?

Innovation in Heart Transplant: The Future of the Field

HFpEF

Role of Diet, Nutrition, & Body Composition in Patients with HF

Dismantling Historical Systems of Inequity to Improve Access to Advanced Heart Failure Therapies for Diverse Populations

Pulmonary Arterial Hypertension: Providing Comprehensive Care Based on Risk

Virtual Health

Best of JCF and HF Journal Round Table

Innovative Strategies for Better LVAD Outcomes

Excellence in Translational Science

Reexamining the 2018 Change in Heart Transplant Allocation Decisions: Are We Better Off Now?

Defining Constructs of HF: Biomarkers to Symptoms

Cardiac Amyloidosis

Emerging Devices/Procedures for Heart Failure

The Right Heart: No More the Forgotten Side Joint Session Canadian HF Society (CHFS)

Care Transitions: Methods, Medications, Metrics, and More!

COVID and the HF Clinician

DEBATE: Optimal Medical Therapy for HFrEF, Death of HVAD, and Oral Inotropy

Peripartum Cardiomyopathy

JNC New Investigators Award

Nursing New Investigator Award

Late Breaking Clinical Trials II

Unintended Side Effects: Polypharmacy, adherence, & financial toxicity of evolving GDMT for HF

Clinical Conundrums

Lessons for HF Care from the Pandemic: Imagining a Better New Normal (Plenary)

Revascularization in HF (Joint Session IASC)